ARYZTA (ARYN) Q3 2024 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 TU earnings summary
13 Jun, 2025Executive summary
Achieved 2.0% organic growth in Q3 2024, with a strong 3.2% volume rebound despite weak consumer spending.
Recovery in QSR continued, while Retail and Other Foodservice segments performed solidly.
Nine-month organic growth was 0.2%, with Europe slightly negative and Rest of World up 3.3%.
Financial highlights
Q3 2024 group revenue reached €552.2m, up 2.5% year-over-year.
Nine-month group revenue totaled €1,607.4m, with currency movement contributing 0.5%.
Negative price impact of (1.1)% in Q3, with mix slightly negative at (0.1)%.
Outlook and guidance
Full year organic growth targeted at the lower end of low to mid-single digit guidance.
Mid-term EBITDA margin target remains on track through business improvements and cost management.
No deflationary trend expected due to ongoing price volatility and cost inflation.
Latest events from ARYZTA
- Revenue, EBITDA, and cash flow rose; capital return policy and bond repurchase set for 2026.ARYN
Q4 20252 Mar 2026 - EBITDA margin rose to 14.2% on €1,055.2m revenue, with leverage down to 2.9x.ARYN
H1 20241 Feb 2026 - FY2025 targets exceeded, with strong EBITDA, cash flow, and major investment in Portugal.ARYN
Q4 2025 TU22 Jan 2026 - EBITDA guidance reset to €300m for 2025; interim CEO appointed to drive improvements.ARYN
Investor Update14 Dec 2025 - Midterm targets met early, with higher margins, strong cash flow, and double-digit EPS growth.ARYN
H2 202410 Dec 2025 - Revenue and EPS rose, with margin pressured by inflation but guidance reaffirmed.ARYN
H1 202523 Nov 2025 - Targets above-market growth and >15% EBITDA margin by 2028 through innovation and efficiency.ARYN
CMD 202517 Nov 2025 - Q3 organic growth 0.8%, YTD 2.1%, FY25: €300m EBITDA, €100m free cash flow, cost optimisation.ARYN
Q3 2025 TU20 Oct 2025 - Innovation-led growth, margin expansion, and strong cash flow drive ARYZTA's robust performance.ARYN
Investor Presentation13 Jun 2025